Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    09-October-2000      
Issue 179 Next Update - 14:00 UTC 08:00 EST    10-October-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 09-October-2000:

Two Americans and a Swede, Arvid Carlsson, Paul Greengard and Eric Kandel, won the Nobel Prize in medicine for discoveries about how messages are transmitted between brain cells, work that has paid off for treating Parkinson's disease and depression.

In unrelated news, this Vidyya contains the September 2000 report: AIDS No Time to Spare: The Final Report to the President of the United States. At the dawn of the new millennium, there is no threat to the global community that demands more urgent leadership and response than HIV/AIDS. The devastation wrought by HIV/AIDS during the past 20 years is almost unimaginable. Globally, nearly 19 million people have died; another 34 million are living with HIV/AIDS, mostly in the poorest regions of the world. In the United States, over 400,000 individuals have died of AIDS and another 700-900,000 are living with the virus.

On the subject of AIDS, clinicians surfing the web will find that patient-oriented clinical fact sheets on HIV disease are produced by numerous agencies and organizations. To help you sort through the wealth of information this issue contains fact sheets that are indexed and available in English, French, and Spanish by topic, so that providers and patients can easily find a desired monograph at an appropriate reading level. Users should compare fact sheets for a given topic and decide which is most up-to-date and best-suited to their needs, as fact sheet producers have different editorial viewpoints and update schedules. Fact sheet producers may offer other fact sheets in addition to those listed in this issue.

In other infectious disease news, Becton Dickinson Biosciences (Sparks, Maryland) has issued a voluntary recall of a lot of isoniazid [INH] (drug lot no. 9335260) used for antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis. The recalled INH lot was sold as components of BACTEC™* S.I.R.E. kits (lot nos. 9327296, 9342298, and 9327298) and as individual drug for reconstitution (BACTEC™ Isoniazid kit lot no. 9327297) during January 2000--August 25, 2000.

Since tuberculosis is frequently in the news, Vidyya presents this resource from the Centers for Disease Control. The Core Curriculum on Tuberculosis - What the Clinician Should Know - is an informative curriculum designed to present basic information about TB for health care professionals. It is intended for use as a reference manual for clinicians caring for persons with or at high risk for TB disease or infection. In addition, it was designed to be useful in developing educational programs.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.